4D Molecular Therapeutics Inc (FDMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | -977 | 7,421 | 3,633 | 3,535 | 0 |
| Gross Profit | 4,444 | 7,421 | 3,633 | 3,535 | N/A |
| Operating Expenses | 19,445 | 15,237 | 18,782 | 16,812 | 0 |
| Operating Income | -20,422 | -7,816 | -15,149 | -13,277 | N/A |
| Other Income | -125 | -17 | -4 | 117 | 0 |
| Pre-tax Income | -20,547 | -7,833 | -15,153 | -13,160 | 0 |
| Net Income Continuous | -20,547 | -7,833 | -15,153 | -13,160 | N/A |
| Net Income | $-20,547 | $-7,833 | $-15,153 | $-13,160 | $N/A |
| EPS Basic Total Ops | -1.85 | -1.51 | -2.92 | -2.54 | N/A |
| EPS Basic Continuous Ops | -1.85 | -1.51 | -2.92 | -2.54 | N/A |
| EPS Diluted Total Ops | -1.85 | -1.51 | -2.92 | -2.54 | N/A |
| EPS Diluted Continuous Ops | -1.85 | -1.51 | -2.92 | -2.54 | N/A |
| EBITDA(a) | $-20,051 | $-7,447 | $-14,790 | $-12,933 | $N/A |